Daniel Arias
Stock Analyst at Stifel
(4.46)
# 331
Out of 4,479 analysts
91
Total ratings
61.7%
Success rate
15.9%
Average return
Main Sectors:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $163 → $151 | $125.78 | +20.05% | 12 | May 30, 2024 | |
| BRKR Bruker | Maintains: Hold | $81 → $77 | $61.64 | +24.92% | 3 | May 20, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,270 → $1,510 | $1,357.07 | +11.27% | 4 | May 13, 2024 | |
| WAT Waters | Maintains: Hold | $330 → $332 | $284.49 | +16.70% | 10 | May 8, 2024 | |
| QGEN Qiagen | Maintains: Hold | $55 → $45 | $40.70 | +10.57% | 3 | May 1, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $63 → $53 | $18.87 | +180.87% | 4 | May 1, 2024 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $11 → $10 | $6.84 | +46.20% | 2 | Feb 23, 2024 | |
| RGEN Repligen | Maintains: Buy | $165 → $207 | $120.14 | +72.30% | 6 | Feb 22, 2024 | |
| RVTY Revvity | Maintains: Hold | $95 → $110 | $102.01 | +7.83% | 1 | Feb 2, 2024 | |
| TECH Bio-Techne | Downgrades: Hold | $65 | $71.24 | -8.76% | 8 | Feb 2, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $660 → $530 | $533.93 | -0.74% | 9 | Oct 26, 2023 | |
| ILMN Illumina | Reiterates: Buy | $200 | $105.51 | +89.56% | 12 | Oct 12, 2023 | |
| CDXS Codexis | Maintains: Buy | $9 → $5 | $2.89 | +73.01% | 2 | Aug 14, 2023 | |
| DHR Danaher | Maintains: Hold | $250 → $240 | $240.41 | -0.17% | 3 | Jul 26, 2023 | |
| EXAS Exact Sciences | Reiterates: Buy | $85 | $43.17 | +96.90% | 3 | Jun 21, 2023 | |
| RNLX Renalytix | Maintains: Buy | $17 → $7 | $0.25 | +2,667.89% | 2 | Jul 1, 2022 | |
| ABSI Absci | Maintains: Hold | $28 → $10 | $2.97 | +236.70% | 2 | May 31, 2022 | |
| AVTR Avantor | Maintains: Buy | n/a | $20.58 | - | 3 | Sep 10, 2021 | |
| MXCT MaxCyte | Initiates: Buy | n/a | $3.72 | - | 1 | Aug 24, 2021 | |
| MASS 908 Devices | Initiates: Buy | n/a | $4.73 | - | 1 | Jan 12, 2021 |
Agilent Technologies
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $125.78
Upside: +20.05%
Bruker
May 20, 2024
Maintains: Hold
Price Target: $81 → $77
Current: $61.64
Upside: +24.92%
Mettler-Toledo International
May 13, 2024
Maintains: Buy
Price Target: $1,270 → $1,510
Current: $1,357.07
Upside: +11.27%
Waters
May 8, 2024
Maintains: Hold
Price Target: $330 → $332
Current: $284.49
Upside: +16.70%
Qiagen
May 1, 2024
Maintains: Hold
Price Target: $55 → $45
Current: $40.70
Upside: +10.57%
10x Genomics
May 1, 2024
Maintains: Buy
Price Target: $63 → $53
Current: $18.87
Upside: +180.87%
Maravai LifeSciences Holdings
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $6.84
Upside: +46.20%
Repligen
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $120.14
Upside: +72.30%
Revvity
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $102.01
Upside: +7.83%
Bio-Techne
Feb 2, 2024
Downgrades: Hold
Price Target: $65
Current: $71.24
Upside: -8.76%
Thermo Fisher
Oct 26, 2023
Maintains: Buy
Price Target: $660 → $530
Current: $533.93
Upside: -0.74%
Illumina
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $105.51
Upside: +89.56%
Codexis
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.89
Upside: +73.01%
Danaher
Jul 26, 2023
Maintains: Hold
Price Target: $250 → $240
Current: $240.41
Upside: -0.17%
Exact Sciences
Jun 21, 2023
Reiterates: Buy
Price Target: $85
Current: $43.17
Upside: +96.90%
Renalytix
Jul 1, 2022
Maintains: Buy
Price Target: $17 → $7
Current: $0.25
Upside: +2,667.89%
Absci
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.97
Upside: +236.70%
Avantor
Sep 10, 2021
Maintains: Buy
Price Target: n/a
Current: $20.58
Upside: -
MaxCyte
Aug 24, 2021
Initiates: Buy
Price Target: n/a
Current: $3.72
Upside: -
908 Devices
Jan 12, 2021
Initiates: Buy
Price Target: n/a
Current: $4.73
Upside: -